Sotevtamab
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Sotevtamab, covering 2025-02-19 to 2026-03-23. Get the full timeline:
Most recent: Clinical Trial Update: Open-Label, Phase 1 Clinical Trial of Neoadjuvant Nogapendekin Alfa Inbakicept, Sotevtamab, and Zabadinostat in Combination With Gemcitabine and Nab-Paclitaxel for Participants With Borderline Resectable or Locally Advanced Pancreatic Cancer [Phase 1]